HIV incidence in sub-Saharan Africa has declined substantially, according to both UNAIDS estimates and empirical data pulled ...

PEPFAR, a global program to combat AIDS, faces an existential threat due to partisan politics, but Congress has an opportunity to reform the program and ensure its continued success.

Gilead is set to launch a Phase III trial of its once-yearly lenacapavir pre-exposure prophylaxis (PrEP) for human ...

Remain paused as the waiver related to USAID funding has not been operationalized. Global Fund (GF): The Global Fund is considering using savings to maintain the national electronic register as an ...

GENEVA, 6 March 2025 – Ahead of International Women’s Day, 8 March, UNAIDS calls for renewed efforts in support of gender ...

Lenacapavir, which stops HIV from replicating inside cells, has passed early safety tests.

Innovation in HIV care and prevention is transforming the fight, but there is more to be done in order to meet the UNAIDS targets of ending the HIV epidemic by 2030 ...

In a report this week, UNAIDS said at least 55 countries around the world had reported funding cuts to HIV programmes, including several in African countries. That included halts to 55 HIV projects ...

A new report, released by the United Nations (UN) agency with responsibility for responding to HIV/AIDS, says the decision by ...

Prevalence varies by region and is impacted by social stigma, access to preventive medicine and a lack of HIV/AIDS education, ...